Jiandong Wang

ORCID: 0000-0002-8560-3884 · 5 papers in corpus
review 2025
Frontiers in pharmacology ·doi:10.3389/fphar.2025.1702273

Ovarian cancer, particularly epithelial ovarian cancer (EOC), is the most aggressive and lethal gynecologic malignancy, necessitating the development of innovative and potent therapies to improve its prognosis. Human polo-like kinase 1 (PLK…

other 2025
Journal of ovarian research ·doi:10.1186/s13048-025-01729-9

Ovarian cancer ranks as the eighth most common malignancy in women globally. Early detection remains a critical challenge for improving ovarian cancer diagnosis and treatment outcomes. Our prior study demonstrated that ARHGAP40 downregulati…

observational 2024
International journal of women's health ·doi:10.2147/ijwh.s500936

PURPOSE: To evaluate the insulin resistance in patients with menopause who were newly diagnosed with endometrial cancer and its association with disease development. METHODS: The study included 356 patients with menopause who underwent hys…

lab-animal 2021
International Immunopharmacology ·doi:10.1016/j.intimp.2021.108067

Acute pancreatitis (AP) is an inflammatory disease of the pancreas. Accumulating studies have revealed the involvement of tumor necrosis factor alpha-induced protein 3 (TNFAIP3) in the progression of AP. Here, the current study was conducte…

nonrandomized-trial 2005
Zhonghua fu chan ke za zhi

OBJECTIVE: To observe the change of lipid metabolic parameters, sex hormone and bone mineral density (BMD) in patients with endometriosis before and after oral administration of gestrinone. METHODS: Fifty-six patients with endometriosis, a…